OCC 1.25% 39.5¢ orthocell limited

Ann: Ortho-ATI Shoulder Tendon Study Database Lock, page-93

  1. 761 Posts.
    lightbulb Created with Sketch. 120
    It is true that more fail than succeed but of the companies that fail most had all their eggs in one basket, a billion shares on the register and deep in debt trying to scrape together trials. Orthocell is in a remarkable position, not only no debt but money in the bank, only 200 million shares and lots of the time consuming trial done or near done. Not to mention fda approved and near term income stream. Also a number of different products with many applications. If i had to compare it to any company i can think of i would say cochlear.

    Think i have just talked myself into topping up again.
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
(20min delay)
Last
39.5¢
Change
-0.005(1.25%)
Mkt cap ! $82.68M
Open High Low Value Volume
40.0¢ 40.0¢ 39.0¢ $54.39K 137.5K

Buyers (Bids)

No. Vol. Price($)
1 2298 39.5¢
 

Sellers (Offers)

Price($) Vol. No.
40.0¢ 193037 5
View Market Depth
Last trade - 12.41pm 12/07/2024 (20 minute delay) ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.